HOW CANCERFAX HELPS
INTERNATIONAL CANCER PATIENTS
From second opinions and treatment summaries to clinical trial matching and cross-border care coordination โ CancerFax is the specialist bridge between cancer patients and the world's most advanced oncology centres.
analyticsAt a Glance
- check_circleWe support patients with advanced, rare, or treatment-resistant cancers seeking options beyond their local system
- check_circleOur team reviews your medical records and identifies clinically appropriate options โ not generic referrals
- check_circleWe coordinate with leading centres in China and India, covering CAR-T, gene therapy, immunotherapy, and clinical trials
- check_circleFamilies can use CancerFax from any country โ our service is fully international
What Is CancerFax?
CancerFax is a specialist cancer access and patient-navigation platform. We exist for one purpose: to help patients and families facing complex, advanced, or rare cancers find and access the best possible treatment options โ wherever in the world those options exist.
โThe right treatment exists somewhere in the world. CancerFax helps you find it.โ
Not a Referral Agency
CancerFax is not a generic referral service. Every case is reviewed by our medical team, and recommendations are clinically driven โ based on your diagnosis, histology, biomarkers, and treatment history.
Not a Hospital
We do not provide medical treatment directly. We are the bridge โ reviewing your case, identifying options, coordinating with specialist centres, and supporting you through the access process.
How CancerFax Works โ Step by Step
Our process is designed to move efficiently from your first contact to a concrete treatment recommendation โ typically within days, not weeks.
- 1
Submit Your Medical Records
Upload your pathology reports, imaging, treatment history, and any prior second opinions through our secure portal or by email. We accept records in any language.
- 2
Medical Summary Preparation
Our clinical team organises your records into a structured oncology summary โ standardised for international review, with key findings, biomarker results, and treatment timeline clearly presented.
- 3
Case Review and Option Mapping
A CancerFax specialist reviews your case and maps available options โ including advanced therapies, clinical trials, and second opinion pathways at relevant international centres.
- 4
Hospital and Specialist Coordination
We communicate directly with oncologists at partner centres in China, India, and internationally to confirm eligibility, obtain treatment cost estimates, and arrange consultation appointments.
- 5
Travel and Logistics Support
For patients travelling to treatment centres, we assist with medical visa letters, airport transfers, interpreter arrangements, accommodation near the hospital, and companion support.
- 6
Ongoing Follow-Up
We remain involved throughout treatment โ coordinating between your local oncologist and the treating centre, translating reports, and ensuring continuity of care after you return home.
What Types of Cases We Support
CancerFax is most valuable for patients where standard local treatment is limited, exhausted, or where advanced options elsewhere are not easily accessible without specialist guidance.
Advanced & Recurrent Cancer
Stage III/IV solid tumours, haematological malignancies, and cancers that have progressed after first or second-line treatment โ where novel therapies are urgently needed.
Rare and Difficult-to-Treat Cancers
Rare tumour types, sarcomas, rare leukaemias, paediatric malignancies, and cancers with unusual histology or molecular profiles that require specialist expertise.
Second Opinion Requests
Patients who want expert review of their diagnosis, treatment plan, or pathology results from a leading oncologist at a major academic centre before committing to a treatment course.
Clinical Trial Access
Identifying open trials for specific diagnoses, biomarkers, or treatment lines โ including Phase I/II trials in China and India that may not appear on ClinicalTrials.gov.
CancerFax โ Key Facts
Our platform connects patients to a global network of specialist oncology centres with a focus on advanced therapy access.
- 50+Countries where we have supported patientsTruly international โ CancerFax works across Asia, the Middle East, Africa, Europe, and beyond.
- 100+Partner hospitals and oncology centresSpanning China, India, Germany, South Korea, Turkey, and other major oncology destinations.
- 72 hrsTypical time from record submission to options reportFast turnaround is critical when patients are facing advanced disease.
Advanced Therapies Available Through CancerFax
Our strongest access corridor is China and India, where many advanced cancer therapies are available โ often at substantially lower cost than Western markets and with shorter waiting times.
| Therapy Type | Key Indications | Access via CancerFax |
|---|---|---|
| CAR-T Cell Therapy | Relapsed/refractory B-cell lymphoma, ALL, myeloma | China (CFDA-approved + investigational) |
| Gene Therapy | Haemoglobinopathies, selected solid tumours | China academic centres, India |
| Oncolytic Virus Therapy | Glioblastoma, head & neck, liver cancer | China (H101 approved; trials ongoing) |
| Immunotherapy / PD-1/PD-L1 | Lung, liver, gastric, cervical, and others | China, India โ including Chinese biosimilars |
| Interventional Oncology | HCC, metastatic liver disease, NSCLC | China specialist centres |
| Clinical Trials | Most solid and haematological tumours | China, India, and international registry |
Why China and India for Advanced Cancer Care?
These two countries represent CancerFax's strongest access corridors โ combining clinical innovation, scale, and affordability in ways that Western healthcare systems cannot match.
- 1
China: Innovation at Scale
China has the world's largest CAR-T programme, the only approved oncolytic virus (H101), a rapidly expanding gene therapy pipeline, and hundreds of Phase IโIII trials enrolling internationally.
- 2
India: Quality at Cost
India offers internationally accredited oncology at 20โ40% of Western costs. Major centres in Mumbai, Delhi, Chennai, and Hyderabad have fellowship-trained oncologists and modern infrastructure.
- 3
Access to Domestic Generics and Biosimilars
Both China and India manufacture domestically approved oncology generics (e.g., Chinese bevacizumab, Indian targeted therapy biosimilars) at dramatically lower cost than originator products.
- 4
Shorter Waiting Times
For CAR-T, surgery, and specialist consultations, Chinese and Indian centres typically have significantly shorter waiting times than NHS, Canadian, or European public systems.
CancerFax Support โ Available in Multiple Languages
Our team supports patients in their language โ removing communication barriers from the treatment access process.
- English
- Chinese (Mandarin)
- Arabic
- Hindi
- Bengali
- Russian
- French
More CancerFax Resources
Explore our treatment guides, condition pages, and caregiver resources to understand your options in more detail.
Frequently Asked Questions About CancerFax
Common questions from patients and families exploring our navigation services.
Is CancerFax free to use?
Our initial case review and option mapping service is provided at no charge. For full coordination services โ including hospital liaison, treatment cost negotiation, medical summary preparation, and logistics support โ fees apply depending on the scope of support required. Contact our team for a transparent overview of costs before committing to any service.
What types of cancer does CancerFax support?
All cancer types โ including solid tumours (lung, liver, gastric, colon, breast, cervical, brain), haematological malignancies (lymphoma, leukaemia, myeloma), paediatric cancers, and rare tumours. Our strongest access is for advanced, recurrent, or rare cases where local options are limited.
Do I need to travel to use CancerFax?
No. Many of our services โ including second opinion coordination, medical summary preparation, and clinical trial identification โ are delivered remotely. Travel is only required if you decide to pursue treatment at an international centre, and we support the logistics of that journey if needed.
How does CancerFax select which hospitals to work with?
Partner hospitals are assessed on their oncology specialisation, clinical outcomes data, international patient infrastructure, regulatory status, and the quality and responsiveness of their coordination teams. We do not work with all hospitals that approach us โ clinical quality and patient experience are the primary criteria.
Can CancerFax help if I have already started treatment?
Yes โ and in many cases this is exactly when patients contact us. Whether you are seeking a second opinion on your current plan, looking for options at first relapse, or exploring clinical trials after second-line failure, CancerFax can step in at any point in the treatment journey.
How CancerFax Helps
CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.
We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.
We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.
We support appointment coordination, document submission, translation, and direct communication with international departments.
For international patients, we help with practical coordination โ travel planning, hospital admission guidance, and local support.
If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.
From inquiry through to follow-up, our coordinators provide a single point of contact for the family.
CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.
Ready to Explore Your Options?
Send us your medical reports and a CancerFax specialist will review your case and identify the most appropriate advanced treatment options, second opinion pathways, and clinical trials โ at no obligation.
CancerFax provides patient navigation and access facilitation services. We do not provide direct medical treatment. All clinical decisions are made by qualified oncologists at partner institutions.